SEARCH
Quotes News NAV
Financial Ratios Markets  >  Corporate Information  >   Financial Ratios
Krebs Biochemicals & Industries Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524518 INE268B01013 -50.2613955 KREBSBIO 0 156.27 0 0 10
ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.782.230.000.000.00
Long Term Debt-Equity Ratio0.541.740.000.000.00
Current Ratio0.410.450.440.510.50
Fixed Assets0.180.220.210.140.21
Inventory2.782.833.402.794.62
Debtors73.94101.19214.8021.4929.57
Interest Cover Ratio-7.31-7.26-3.52-3.81-2.18
PBIDTM (%)-29.08-55.01-31.56-54.44-19.51
PBITM (%)-41.67-65.56-41.10-68.45-28.73
PBDTM (%)-34.78-64.04-43.26-72.40-32.68
CPM (%)-34.78-64.04-43.28-72.40-32.68
APATM (%)-47.36-74.59-52.81-86.41-41.90
ROCE (%)0.000.000.000.000.00
RONW (%)0.000.000.000.000.00